Elisa Bianchi

10PUBLICATIONS
29CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursOptical technologyPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 14, 2025
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model.

Lara Tavernari, Matteo Bertesi, Anita Neroni

|Aug 23, 2024
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms.

Chiara Carretta, Sandra Parenti, Matteo Bertesi

|Jul 29, 2023
Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up.

Eustachio Attico, Giulia Galaverni, Andrea Torello

|Mar 17, 2023
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model.

Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari

|May 28, 2022
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization.

Eustachio Attico, Giulia Galaverni, Elisa Bianchi

|Jan 21, 2022
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis.

Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli

Pageof 2

Frequent Collaborators

8 joint publications

Rossella Manfredini

6 joint publications

Chiara Carretta

5 joint publications

Paola Guglielmelli

3 joint publications

Lara Tavernari